Kersting, David http://orcid.org/0000-0002-8451-1830
Sraieb, Miriam
Seifert, Robert
Costa, Pedro Fragoso
Kazek, Sandra
Kessler, Lukas
Umutlu, Lale
Fendler, Wolfgang Peter
Jentzen, Walter
Herrmann, Ken
Büther, Florian
Nader, Michael
Rischpler, Christoph
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FU356/12-1)
Universitätsklinikum Essen
Article History
Received: 24 February 2022
Accepted: 26 March 2022
First Online: 12 April 2022
Declarations
:
: All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The local institutional ethics committee (University of Duisburg-Essen, medical faculty) approved the study (Ethics protocol number 20–9594-BO).
: Informed consents were obtained from all individual participants included in the study.
: David Kersting reports a research grant from Pfizer, outside the submitted work. Lale Umutlu is a Speaker/Advisory Board Member for Bayer Healthcare and Siemens Healthcare and received research grants from Siemens Healthcare, outside the submitted work. Wolfgang P. Fendler is a consultant for BTG, and he received fees from RadioMedix, Bayer, and Parexel, outside the submitted work. Walter Jentzen received research funding from Siemens Healthineers, outside the submitted work. Ken Herrmann reports personal fees from Bayer, Sofie Biosciences, SIRTEX, Adacap, Curium, Endocyte, IPSEN, Siemens Healthineers, GE Healthcare, Amgen, Novartis, ymabs, Aktis, Oncology, Pharma15; non-financial support from ABX; grants and personal fees from BTG, outside the submitted work. Christoph Rischpler reports a research grant from Pfizer, consultancy for Adacap and Pfizer, speaker honoraria from Adacap, Alnylam, BTG, GE Healthcare, Pfizer and Siemens Healthineers, outside the submitted work. No other potential conflict of interest was reported.